Why BioNTech Stock Is Plunging Today
Published
Good news for Pfizer was seen as potentially bad news for BioNTech.
Full ArticlePublished
Good news for Pfizer was seen as potentially bad news for BioNTech.
Full ArticleInvestors appear to think last week's sell-off was overdone.
Moderna's disappointing Q3 report appears to be dragging BioNTech's shares down with it..